We have demonstrated previously that there is an abnormal expression of sphingomyelin (SM) deacylase in the epidermis of patients with atopic dermatitis (ADe). In the present study, we have prepared N-[palmitic acid-1-14C]SM and N-[palmitic acid-1-14C]glucosylceramide (GCer) to use as substrates and have quantified SM deacylase activity by detecting the release of [14C]palmitic acid in extracts of the stratum corneum or the epidermis of ADe patients. In studies using [palmitic acid-1-14C]SM as a substrate, a pH dependency of catalytic activity with a peak at pH 5.0 was found. Preparative SDS/PAGE using an extract of ADe epidermis revealed that the molecular mass of SM deacylase is 40000Da, which is consistent with its apparent molecular mass of 42000Da estimated by gel-filtration analysis of stratum corneum extracts. Analytical isoelectric focusing (IEF) chromatography demonstrated that the pI values of SM deacylase, β-glucocerebrosidase (GlcCDase), sphingomyelinase (SMase) and acid ceramidase were 4.2, 7.4, 7.0 and 5.7, respectively. In enzymic analysis using pI-4.2 SM deacylase partially purified by IEF, which had no detectable contamination with acid ceramidase, GlcCDase or SMase, radio-TLC analysis revealed that radiolabelled sphingosylphosphocholine or [1-14C]palmitic acid was enzymically liberated from [choline-methyl-14C]SM or N-[palmitoyl-1-14C]GCer, respectively, used as substrates. Further the pI-4.2 protein purified from extracts of the stratum corneum of ADe patients was able to hydrolyse N-[palmitoyl-1-14C]SM and GCer, but not N-[palmitoyl-1-14C]ceramide. These results indicate that a hitherto undiscovered epidermal enzyme, termed here glucosylceramide sphingomyelin deacylase, is expressed in the skin of ADe patients, which plays an important role in ceramide deficiency (including acylceramides) in the stratum corneum.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
September 2000
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
Research Article|
September 08 2000
The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide Available to Purchase
Kazuhiko HIGUCHI;
Kazuhiko HIGUCHI
*Department of Dermatology, Tokyo Women's Medical University, Tokyo, Japan
Search for other works by this author on:
Junko HARA;
Junko HARA
*Department of Dermatology, Tokyo Women's Medical University, Tokyo, Japan
Search for other works by this author on:
Reiko OKAMOTO;
Reiko OKAMOTO
*Department of Dermatology, Tokyo Women's Medical University, Tokyo, Japan
Search for other works by this author on:
Makoto KAWASHIMA;
Makoto KAWASHIMA
*Department of Dermatology, Tokyo Women's Medical University, Tokyo, Japan
Search for other works by this author on:
Genji IMOKAWA
Genji IMOKAWA
1
†Biological Science Laboratories, Kao Corporation, 2606 Akabane, Ichikai-machi, Haga, Tochigi 321-3497, Japan
1To whom correspondence should be addressed (e-mail [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
January 17 2000
Revision Received:
June 12 2000
Accepted:
July 11 2000
Online ISSN: 1470-8728
Print ISSN: 0264-6021
The Biochemical Society, London © 2000
2000
Biochem J (2000) 350 (3): 747–756.
Article history
Received:
January 17 2000
Revision Received:
June 12 2000
Accepted:
July 11 2000
Citation
Kazuhiko HIGUCHI, Junko HARA, Reiko OKAMOTO, Makoto KAWASHIMA, Genji IMOKAWA; The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. Biochem J 15 September 2000; 350 (3): 747–756. doi: https://doi.org/10.1042/bj3500747
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |